Creative Biolabs-Immuno-oncology

Anti-KDR (clone R8P4I/PGN3) SynExpress T7-G-I17-B Modified CD8+ T cells (CAT#: ITS-1224-CR159)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target KDR (clone R8P4I/PGN3). We employs the Lentivirus (T7-GFP-IL-17-BamHI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
KDR
Clone
R8P4I/PGN3
Species Reactivity
Human; Mouse
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
Lentivirus
Transformation Accuracy
0.93
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.